AN2 Therapeutics ANTX Cash Flow Statement (2021-2026)

NASDAQ ANTX
$3.64 +0.08 (+2.25%)
As of: Oct 21, 2026 · 2:31 PM EDT
Reported Financials

AN2 Therapeutics Quarterly Cash Flow Statement

Periods 22 quarters
Latest Jun 2026

AN2 Therapeutics reported cash from operations of -$7.00M and free cash flow of -$7.00M for the quarter ended Jun 2026, up 7.9% year over year. This cash flow statement covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-6.94M-7.55M-7.66M-10.12M-11.34M-11.84M-15.32M-15.80M-16.71M-16.90M-16.62M-14.44M-12.75M-7.52M-10.65M-6.50M-9.35M-8.67M-10.03M-8.20M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.00M
Share-based CompensationStock Comp.
0.35M0.43M0.45M1.24M1.23M1.47M2.07M1.94M2.17M2.23M2.39M2.27M1.90M1.78M2.05M2.00M0.80M1.40M1.46M0.97M
Other non-cash itemsOther Non-Cash
0.02M0.02M0.02M0.02M0.02M0.02M0.01M
Change in Working Capital
Change in Account PayablesChange Payables
0.71M-0.95M1.55M0.44M-0.17M0.68M1.42M-0.41M1.65M-2.11M-0.24M-0.55M-0.17M1.61M-0.24M-0.96M0.11M0.80M-0.41M-1.00M
Change in Accured ExpensesChange Accured Exp.
0.30M-0.27M-0.58M1.26M0.01M1.03M-1.43M5.03M0.12M0.12M-3.02M0.85M0.27M-0.43M-1.15M-0.35M-0.25M-0.65M-1.81M0.48M
Change in Other Operating AssetsOther Assets Change
-0.61M1.04M0.57M2.08M-0.63M-0.33M-0.74M1.17M-0.02M0.62M-1.11M0.80M0.32M-0.82M-0.65M1.81M-2.51M-0.16M0.27M-0.72M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.02M-0.02M-0.02M-0.02M-0.02M-0.02M0.96M-0.31M-0.35M0.24M0.72M-0.48M-0.42M0.35M-0.53M1.22M-0.66M0.21M
Other Working Capital ChangesOther WC Changes
0.61M-1.04M-0.58M-2.10M0.61M0.31M0.72M-1.19M0.98M-0.93M0.76M-0.56M0.40M0.33M0.22M-1.46M1.98M1.38M-0.93M0.93M
Cash from OperationsCash from Ops.
-4.69M-8.99M-6.74M-9.60M-9.49M-7.64M-11.60M-12.82M-11.80M-17.07M-17.60M-14.40M-12.00M-5.26M-10.62M-7.60M-6.38M-5.23M-12.10M-7.00M
Investing Activities
Purchase of InvestmentsInvestments Purchased
11.99M16.00M1.00M52.99M22.41M17.45M14.01M13.12M85.21M19.83M9.78M24.38M22.31M11.67M3.89M8.33M2.70M13.66M
Sale and Maturity of InvestmentsInvestments Sold
22.25M14.98M13.50M20.09M23.50M24.90M21.00M22.75M20.25M26.29M29.05M28.50M17.50M31.50M17.50M10.00M15.50M10.99M10.00M
Cash from Investing ActivitiesCash from Investing
-6.99M6.25M13.98M-39.49M-2.32M6.06M10.89M7.88M-62.46M0.42M26.29M16.46M18.72M-6.88M9.19M5.83M6.11M7.17M8.29M-3.66M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
0.00M63.20M7.18M-0.01M0.20M19.05M0.27M0.35M0.02M0.07M0.05M0.06M0.05M
Shares Repurchased
0.01M
Net Shares Issued and RepurchasedNet Shares Issued
0.00M63.19M7.18M-0.01M0.20M19.05M0.27M0.35M0.02M0.07M0.05M0.06M0.05M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.00M63.19M7.18M-0.01M0.20M19.05M0.27M0.35M0.02M0.07M0.05M0.06M0.05M
Other financing activitiesOther financing
-0.97M
Cash from Financing ActivitiesCash from Financing
-0.24M-0.97M63.19M7.18M-0.01M0.20M19.05M66.07M-0.32M0.35M0.02M0.07M0.05M37.33M1.49M
Additional items
Change in Cash
-11.92M-3.72M70.42M-41.90M-11.81M-1.58M-0.51M14.10M-8.20M-16.97M9.05M2.08M6.74M-12.15M-1.37M-1.77M-0.22M1.94M33.55M-9.17M
Ending Cash Balance
15.81M12.10M82.52M40.62M28.80M27.22M26.71M40.81M32.62M15.65M24.69M26.77M33.50M21.35M19.99M18.22M18.00M19.94M53.49M44.32M
Free Cash FlowFCF
-4.69M-8.99M-6.74M-9.60M-9.49M-7.64M-11.60M-12.82M-11.80M-17.07M-17.60M-14.40M-12.00M-5.26M-10.62M-7.60M-6.38M-5.23M-12.10M-7.00M
Net Cash FlowNCF
-11.92M-3.72M70.42M-41.90M-11.81M-1.58M-0.51M14.10M-8.20M-16.97M9.04M2.06M6.74M-12.14M-1.37M-1.77M-0.22M1.94M33.52M-9.17M

AN2 Therapeutics Cash Flow Statement API

Pull AN2 Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ANTX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY